JP7897229B2 - 改変放出ソフトゲルカプセル - Google Patents

改変放出ソフトゲルカプセル

Info

Publication number
JP7897229B2
JP7897229B2 JP2023523094A JP2023523094A JP7897229B2 JP 7897229 B2 JP7897229 B2 JP 7897229B2 JP 2023523094 A JP2023523094 A JP 2023523094A JP 2023523094 A JP2023523094 A JP 2023523094A JP 7897229 B2 JP7897229 B2 JP 7897229B2
Authority
JP
Japan
Prior art keywords
release
approximately
composition
softgel capsule
modified release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023523094A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023547062A (ja
JP2023547062A5 (cg-RX-API-DMAC10.html
Inventor
スクル,カルナカー
ファング,チー
Original Assignee
アール.ピー.シェーラー テクノロジーズ,エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アール.ピー.シェーラー テクノロジーズ,エルエルシー filed Critical アール.ピー.シェーラー テクノロジーズ,エルエルシー
Publication of JP2023547062A publication Critical patent/JP2023547062A/ja
Publication of JP2023547062A5 publication Critical patent/JP2023547062A5/ja
Application granted granted Critical
Publication of JP7897229B2 publication Critical patent/JP7897229B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2023523094A 2020-10-16 2021-10-15 改変放出ソフトゲルカプセル Active JP7897229B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063092762P 2020-10-16 2020-10-16
US63/092,762 2020-10-16
PCT/US2021/071900 WO2022082222A1 (en) 2020-10-16 2021-10-15 Modified release softgel capsules

Publications (3)

Publication Number Publication Date
JP2023547062A JP2023547062A (ja) 2023-11-09
JP2023547062A5 JP2023547062A5 (cg-RX-API-DMAC10.html) 2024-10-22
JP7897229B2 true JP7897229B2 (ja) 2026-07-29

Family

ID=81208677

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023523094A Active JP7897229B2 (ja) 2020-10-16 2021-10-15 改変放出ソフトゲルカプセル

Country Status (13)

Country Link
US (1) US20230390210A1 (cg-RX-API-DMAC10.html)
EP (1) EP4228597A4 (cg-RX-API-DMAC10.html)
JP (1) JP7897229B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230088388A (cg-RX-API-DMAC10.html)
CN (1) CN116322655A (cg-RX-API-DMAC10.html)
AR (1) AR123805A1 (cg-RX-API-DMAC10.html)
AU (1) AU2021362248A1 (cg-RX-API-DMAC10.html)
BR (1) BR112023006154A2 (cg-RX-API-DMAC10.html)
CA (1) CA3194160A1 (cg-RX-API-DMAC10.html)
CO (1) CO2023005753A2 (cg-RX-API-DMAC10.html)
IL (1) IL301715A (cg-RX-API-DMAC10.html)
MX (1) MX2023004418A (cg-RX-API-DMAC10.html)
WO (1) WO2022082222A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117705978A (zh) * 2023-12-14 2024-03-15 河南泰丰生物科技有限公司 一种四烯甲奈醌软胶囊溶出曲线的测定方法
CN122458978A (zh) * 2023-12-22 2026-07-24 花王株式会社 胶囊剂

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120301546A1 (en) 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
US20150366814A1 (en) 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61151127A (ja) * 1984-12-25 1986-07-09 Meiji Milk Prod Co Ltd ビフイズス菌含有ソフトカプセルの製造方法
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US7842307B2 (en) * 2001-08-06 2010-11-30 Purdue Pharma L.P. Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
DE60238269D1 (de) * 2001-11-22 2010-12-23 Morishita Jintan Co Nicht-gelatinöse Kapseln
KR100575199B1 (ko) * 2003-01-24 2006-05-02 알앤피코리아주식회사 연질 캡슐의 블루밍 방지를 위한 가소제 조성물 및 이를함유한 피막
IT1401313B1 (it) * 2010-08-05 2013-07-18 Perfetti Van Melle Spa Caramelle gelatinose con ripieno fluido e metodo di ottenimento
GB201304662D0 (en) * 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
GB201319792D0 (en) * 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US9877971B2 (en) * 2015-06-15 2018-01-30 Banner Life Sciences Llc Soft lozenges comprising corticosteroids
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
AU2019362883B2 (en) * 2018-10-16 2025-07-31 Bayer Healthcare Llc Softgels with solid or gel-like polymeric fill matrix
EP4674410A3 (en) * 2019-10-28 2026-03-18 R.P. Scherer Technologies, LLC Delayed release softgel capsules in higher ph environment

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120301546A1 (en) 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
US20150366814A1 (en) 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Journal of Food Science and Agricultural Technology,2015年,Vol.1, No.1,pp.26-30

Also Published As

Publication number Publication date
MX2023004418A (es) 2023-05-04
CO2023005753A2 (es) 2023-05-29
IL301715A (en) 2023-05-01
AR123805A1 (es) 2023-01-11
KR20230088388A (ko) 2023-06-19
TW202228656A (zh) 2022-08-01
CN116322655A (zh) 2023-06-23
WO2022082222A1 (en) 2022-04-21
JP2023547062A (ja) 2023-11-09
CA3194160A1 (en) 2022-04-21
BR112023006154A2 (pt) 2023-05-09
AU2021362248A9 (en) 2024-05-02
EP4228597A4 (en) 2024-10-02
US20230390210A1 (en) 2023-12-07
AU2021362248A1 (en) 2023-06-01
EP4228597A1 (en) 2023-08-23

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241011

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241011

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250919

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250924

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251223

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260427

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260707

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260716

R150 Certificate of patent or registration of utility model

Ref document number: 7897229

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150